Perez L A, Hayt D B, Freeman L M
J Nucl Med. 1976 Apr;17(4):241-6.
Myocardial studies with 99mTc-labeled phosphate agents were obtained in 20 patients without demonstrable cardiovascular disease, 24 patients with unstable arteriosclerotic heart disease (ASHD) without acute infarction, and six patients with myocardiopathy. The patients without cardiovascular disease showed no localization or tracer; the patients with unstable ASHD and without acute infarction showed nonfocal ill-defined accumulation of tracer; and the patients with myocardiopathy showed diffuse accummulation of tracer throughout the confines of an enlarged cardiac outline. Careful evaluation of both the distribution and intensity of the activity, in conjunction with the clinical picture, allows differentiation among these disease processes. Since ischemic areas around infarcted tissue may show increased activity, the value of this technique for sizing acute myocardial infarction may be limited.
对20例无明显心血管疾病的患者、24例无急性梗死的不稳定动脉硬化性心脏病(ASHD)患者和6例心肌病患者进行了用99mTc标记的磷酸盐制剂的心肌研究。无心血管疾病的患者未显示示踪剂定位或摄取;无急性梗死的不稳定ASHD患者显示示踪剂非局灶性、边界不清的积聚;心肌病患者显示示踪剂在扩大的心影范围内弥漫性积聚。结合临床表现,仔细评估活性的分布和强度,可以区分这些疾病过程。由于梗死组织周围的缺血区域可能显示活性增加,该技术对急性心肌梗死大小的评估价值可能有限。